Skip to main content

Table 6 Thresholds for treatment calculated using FRAXa and based on LASA cohort data, stratified for age

From: Design of the SALT Osteoporosis Study: a randomised pragmatic trial, to study a primary care screening and treatment program for the prevention of fractures in women aged 65 years or older

Age

Total group

No clinical risk factors for fractures

≥1 clinical risk factors for fractures

Treatment threshold

(yrs)

mean FRAX-score (SD)

N

mean FRAX-score (SD)

N

Mean FRAX-score (SD)

N

 

65-69

12.1 (5.2)

166

8.9 (1.3)

83

15.3 (5.6)

83

>15%

70-74

14.7 (5.8)

187

10.9 (1.6)

90

18.3 (6.0)

97

>18%

75-79

18.6 (7.6)

154

13.2 (2.0)

76

24.0 (7.2)

78

>24%

80-84

22.1 (8.1)

157

17.3 (2.8)

86

28.0 (8.6)

71

>28%

85-91

26.2 (8.1)

101

19.4 (3.1)

44

31.5 (6.8)

57

>32%

  1. FRAX fracture risk assessment tool, LASA Longitudinal Aging Study Amsterdam, SD standard deviation
  2. aUK version of the FRAX tool